NG2 anticorps (AA 1950-2210)
Aperçu rapide pour NG2 anticorps (AA 1950-2210) (ABIN1679389)
Antigène
Voir toutes NG2 (MCSP) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1950-2210
-
Séquence
- LEVPQALGRS SLSQQQLRVV SDREEPEAAY RLIQGPQYGH LLVGGRPTSA FSQFQIDQGE VVFAFTNFSS SHDHFRVLAL ARGVNASAVV NVTVRALLHV WAGGPWPQGA TLRLDPTVLD AGELANRTGS VPRFRLLEGP RHGRVVRVPR ARTEPGGSQL VEQFTQQDLE DGRLGLEVGR PEGRAPGPAG DSLTLELWAQ GVPPAVASLD FATEPYNAAR PYSVALLSVP EAARTEAGKP ESSTPTGEPG PMASSPEPAV A
-
Réactivité croisée
- Humain, Souris, Rat
-
Attributs du produit
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 1950-2210 of human NG2/CSPG4 (NP_001888.2).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB,1:500 - 1:2000,IHC,1:50 - 1:200,IF,1:50 - 1:200
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- NG2 (MCSP) (Melanoma Associated Chondroitin Sulfate Proteoglycan (MCSP))
-
Autre désignation
- CSPG4
-
Sujet
- A human melanoma-associated chondroitin sulfate proteoglycan plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. CSPG4 represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells.,CSPG4,HMW-MAA,MCSP,MCSPG,MEL-CSPG,MSK16,NG2,Cancer,Invasion and Metastasis,Cell Biology & Developmental Biology,Cell Adhesion,Neuroscience,Cell Type Marker,Stem Cells,Cardiovascular,Angiogenesis,Oligodendrocyte marker,CSPG4
-
Poids moléculaire
- 250 kDa
-
ID gène
- 1464
-
UniProt
- Q6UVK1
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-